Sidney Keisner

Sidney Keisner, Pharm.D., BCOP, is a Clinical Associate Professor at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy. He holds dual roles in clinical practice and education, specializing in hematology/oncology pharmacy. His primary affiliation is with the Winthrop P. Rockefeller Cancer Institute where he serves as a Clinical Pharmacist in the Infusion Clinic.

Dr. Keisner's education includes a Doctor of Pharmacy from UAMS (2008), a Bachelor of Arts in Biology from Hendrix College (2004), followed by PGY1 Pharmacy Practice Residency at Parkland Hospital (2009) and PGY2 Hematology/Oncology Residency at Texas Tech University Health Sciences Center (2010).

His research focuses on oncology pharmacotherapy, particularly drug interactions in cancer patients, bone metastasis management, and treatment strategies for prostate and renal cell carcinomas. Notable areas include denosumab's role in skeletal protection, PARP inhibitor efficacy comparisons, and renal toxicity mitigation with bisphosphonates.

Teaching responsibilities include courses like PHPR 7304 (Therapeutics III Oncology) and PHPR 7355 (Drug-Induced Diseases), alongside precepting P4 APPE students. He is a member of the Hematology/Oncology Pharmacy Association.

Publications span 2007–2024, emphasizing clinical case analyses and drug efficacy studies in oncology settings. No awards are explicitly listed, though his work reflects sustained contributions to evidence-based cancer pharmacotherapy.